These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 1706379)
1. Human T cell responses to IL-1 and IL-6 are dependent on signals mediated through CD2. Endler-Jobst B; Schraven B; Hutmacher B; Meuer SC J Immunol; 1991 Mar; 146(6):1736-42. PubMed ID: 1706379 [TBL] [Abstract][Full Text] [Related]
2. Human resting B lymphocytes can serve as accessory cells for anti-CD2-induced T cell activation. Hirokawa M; Gray JD; Takahashi T; Horwitz DA J Immunol; 1992 Sep; 149(6):1859-66. PubMed ID: 1355500 [TBL] [Abstract][Full Text] [Related]
3. Remote T cell co-stimulation via LFA-1/ICAM-1 and CD2/LFA-3: demonstration with immobilized ligand/mAb and implication in monocyte-mediated co-stimulation. Van Seventer GA; Shimizu Y; Horgan KJ; Luce GE; Webb D; Shaw S Eur J Immunol; 1991 Jul; 21(7):1711-8. PubMed ID: 1711977 [TBL] [Abstract][Full Text] [Related]
4. IL-6 is an accessory signal in the alternative CD2-mediated pathway of T cell activation. Lorré K; Van Damme J; Verwilghen J; Baroja ML; Ceuppens JL J Immunol; 1990 Jun; 144(12):4681-7. PubMed ID: 1972166 [TBL] [Abstract][Full Text] [Related]
5. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways. Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293 [TBL] [Abstract][Full Text] [Related]
6. Human T cell activation. Synergy between CD73 (ecto-5'-nucleotidase) and signals delivered through CD3 and CD2 molecules. Massaia M; Perrin L; Bianchi A; Ruedi J; Attisano C; Altieri D; Rijkers GT; Thompson LF J Immunol; 1990 Sep; 145(6):1664-74. PubMed ID: 1975259 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of cytokines on proliferative response of human CD4+ T lymphocyte subsets stimulated via T cell receptor-CD3 complex. Wasik MA; Morimoto C J Immunol; 1990 May; 144(9):3334-40. PubMed ID: 1691754 [TBL] [Abstract][Full Text] [Related]
8. A bidirectional regulatory network involving IL 2 and IL 4 in the alternative CD2 pathway of T cell activation. Lorré K; Van Damme J; Ceuppens JL Eur J Immunol; 1990 Jul; 20(7):1569-75. PubMed ID: 1974850 [TBL] [Abstract][Full Text] [Related]
9. Interaction of CD2 with its ligand lymphocyte function-associated antigen-3 induces adenosine 3',5'-cyclic monophosphate production in T lymphocytes. Hahn WC; Rosenstein Y; Burakoff SJ; Bierer BE J Immunol; 1991 Jul; 147(1):14-21. PubMed ID: 1711070 [TBL] [Abstract][Full Text] [Related]
10. CD59 costimulation of T cell activation. CD58 dependence and requirement for glycosylation. Menu E; Tsai BC; Bothwell AL; Sims PJ; Bierer BE J Immunol; 1994 Sep; 153(6):2444-56. PubMed ID: 7521361 [TBL] [Abstract][Full Text] [Related]
11. "CD3low" human thymocyte populations can readily be triggered via the CD2 and/or CD28 activation pathways whereas the CD3 pathway remains nonfunctional. Pierres A; Cerdan C; Lopez M; Mawas C; Olive D J Immunol; 1990 Feb; 144(4):1202-7. PubMed ID: 1968076 [TBL] [Abstract][Full Text] [Related]
12. CD2 regulates T cell-dependent induction of monocyte IL-1 beta mRNA during anti-CD3 mitogenesis. McAllister PT; Ellis TM Cell Immunol; 1996 May; 170(1):120-6. PubMed ID: 8660807 [TBL] [Abstract][Full Text] [Related]
13. The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor. Bockenstedt LK; Goldsmith MA; Dustin M; Olive D; Springer TA; Weiss A J Immunol; 1988 Sep; 141(6):1904-11. PubMed ID: 2459194 [TBL] [Abstract][Full Text] [Related]
14. Stimulation through the TCR/CD3 complex up-regulates the CD2 surface expression on human T lymphocytes. Alberola-Ila J; Places L; de la Calle O; Romero M; Yagüe J; Gallart T; Vives J; Lozano F J Immunol; 1991 Feb; 146(4):1085-92. PubMed ID: 1671400 [TBL] [Abstract][Full Text] [Related]
15. Activation of cord T lymphocytes. III. Role of LFA-1/ICAM-1 and CD2/LFA-3 adhesion molecules in CD3-induced proliferative response. Gerli R; Agea E; Muscat C; Tognellini R; Fiorucci G; Spinozzi F; Cernetti C; Bertotto A Cell Immunol; 1993 Apr; 148(1):32-47. PubMed ID: 7684326 [TBL] [Abstract][Full Text] [Related]
16. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5. Vandenberghe P; Ceuppens JL Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509 [TBL] [Abstract][Full Text] [Related]
17. Triggering CD 28 molecules synergize with CD 2 (T 11.1 and T 11.2)-mediated T cell activation. Pierrès A; Lopez M; Cerdan C; Nunes J; Olive D; Mawas C Eur J Immunol; 1988 May; 18(5):685-90. PubMed ID: 2454190 [TBL] [Abstract][Full Text] [Related]
18. The required interaction between monocytes and peripheral blood T lymphocytes (T-PBL) upon activation via CD2 or CD3. Role of HLA class I molecules from accessory cells and the differential response of T-PBL subsets. Huet S; Boumsell L; Dausset J; Degos L; Bernard A Eur J Immunol; 1988 Aug; 18(8):1187-94. PubMed ID: 2901355 [TBL] [Abstract][Full Text] [Related]
19. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation. Dang NH; Torimoto Y; Sugita K; Daley JF; Schow P; Prado C; Schlossman SF; Morimoto C J Immunol; 1990 Dec; 145(12):3963-71. PubMed ID: 1979581 [TBL] [Abstract][Full Text] [Related]
20. Signaling requirements for the expression of the transactivating factor NF-AT in human T lymphocytes. Hivroz-Burgaud C; Clipstone NA; Cantrell DA Eur J Immunol; 1991 Nov; 21(11):2811-9. PubMed ID: 1682154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]